Abstract
Purpose
Talniflumate was designed as a prodrug of niflumic acid, a potent analgesic and anti-inflammatory drug, which is widely prescribed for treating rheumatoid diseases. The prandial effect on talniflumate absorption remains unclear; therefore, this study investigated the effect of food on the systemic exposure to niflumic acid in healthy volunteers.
Methods
Volunteers received a single 740-mg dose of talniflumate 30 min after consuming a high-fat breakfast, a low-fat breakfast, or no food (fasting condition). Plasma concentrations of both talniflumate and niflumic acid were measured using validated high-performance liquid chromatography coupled to tandem mass spectrometry.
Results
The maximum concentration of niflumic acid was 224 ± 193 ng/ml at ∼2.7 h in the fasted condition compared with 886 ± 417 ng/ml (p < 0.05) at 1.8 h and 1,159 ± 508 ng/ml (p < 0.01) at 2.2 h with the low- and high-fat meals, respectively. The mean area under the curve from zero to infinity (AUCinf) values after the low- and high-fat meals were four- and fivefold, respectively, the value while fasting (p < 0.05).
Conclusions
It is strongly recommended that talniflumate be taken after a meal to increase systemic exposure to its active metabolite. Our results suggest a reduction in the daily dosage of talniflumate when taken with food.
References
Los M, Boned JE, Piccinali C (1981) New esters of substituted anilinonicotinic and phenylanthranilic acids. Farmaco 36:372–385
Vinci F, Fabbrocino S, Fiori M et al (2006) Determination of fourteen non-steroidal anti-inflammatory drugs in animal serum and plasma by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 20:3412–3420
Lilja JJ, Backman JT, Neuvonen PJ (2007) Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam–probes of CYP2C9, CYP1A2, and CYP3A4. Clin Pharmacol Ther 81:833–839
Grenier J, Fradette C, Morelli G et al (2006) Pomelo juice, but not cranberry juice, affects the pharmacokinetics of cyclosporine in humans. Clin Pharmacol Ther 79:255–262
Dresser GK, Km RB, Bailey DG (2005) Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides. Clin Pharmacol Ther 77:170–177
Thakker KM, Mangat S, Wagner W et al (1992) Effect of food and relative bioavailability following single doses of diclofenac 150 mg hydrogel bead (HGB) capsules in healthy humans. Biopharm Drug Dispos 13:327–335
Bannwarth B, Lapicque F, Netter P et al (1988) The effect of food on the systemic availability of ketoprofen. Eur J Clin Pharmacol 33:643–645
Dressman JB, Berardi RR, Elta GH et al (1992) Absorption of flurbiprofen in the fed and fasted states. Pharm Res 9:901–907
Ishizaki T, Nomura T, Abe T (1979) Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and postprandial states in man. J Pharmacokinet Biopharm 7:369–381
Le Liboux A, Teule M, Frydman A et al (1994) Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen. Eur J Clin Pharmacol 47:361–366
Mroszczak EJ, Jung D, Yee J et al (1990) Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Pharmacotherapy 10:33–39
Forbes JA, Sandberg RA, Bood Bjorklund L (1998) The effect of food on bromfenac, naproxen sodium, and acetaminophen in postoperative pain after orthopedic surgery. Pharmacotherapy 18:492–503
Von Schrader HW, Buscher G, Dierdorf D et al (1983) Nabumetone-a novel anti-inflammatory drug: the influence of food, milk, antacids, and analgesics on bioavailability of single oral doses. Int J Clin Pharmacol Ther Toxicol 21:311–321
Olkkola KT, Neuvonen PJ (1984) Do gastric contents modify antidotal efficacy of oral activated charcoal? Br J Clin Pharmacol 18:663–669
Yun HY, Lee EJ, Chung SY et al (2006) The effects of food on the bioavailability of fenofibrate administered orally in healthy volunteers via sustained-release capsule. Clin Pharmacokinet 45:425–432
Neuvonen PJ, Kivisto KT (1988) Effect of magnesium hydroxide on the absorption of tolfenamic and mefenamic acids. Eur J Clin Pharmacol 35:495–501
Leonard W, Judith A, Davud T (1993) The influence of food on the absorption and metabolism of drugs. Clin Nutr 77:815–829
Leibovitch ER, Deamer RL, Sanderson LA (2004) Careful drug selection and patient counseling can reduce the risk in older patients. Geriatrics 59:19–33
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kang, W., Kim, K., Kim, EY. et al. Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate. Eur J Clin Pharmacol 64, 1027–1030 (2008). https://doi.org/10.1007/s00228-008-0524-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-008-0524-4